Skip to content

UPDATE: We are delighted to announce that EPSRC have funded our CDT for five more years under the new name EPSRC Centre for Doctoral Training in Intelligent Integrated Imaging in Healthcare (i4health).

Visit our new website at:

Prof Mark Emberton

UCL Research Department of Urology

3rd Floor, Charles Bell House

67 Riding House Street




Mark Emberton is a Professor of Interventional Oncology, Division of Surgery and Interventional Science, UCL. His principal interests lie in trying to improve diagnostic and therapeutic pathways for men with prostate cancer, principally through the use of novel imaging techniques and minimally-invasive treatments, e.g. evaluating whether MRI is able to diagnose prostate cancer better. He is the principal investigator in a number of studies in this area. Mark and his team of researchers also have initiated a clinical innovation programme exploring the role of focal therapy in men with prostate cancer. This involves treating only the areas of prostate cancer rather than the whole gland. This, so far, has yielded very promising results, e.g. using a number of technologies such as High Intensity Focused Ultrasound (HIFU) which uses soundwaves to heat and destroy small areas of tissue. The team is also running early trials looking at the role of photodynamic therapy.

UCLH profile